On January 20, 2025, the Trump administration issued Memorandum 2025-01906, imposing a government-wide freeze on all pending federal regulatory actions. The freeze halts the issuance and effective dates of regulations that had not yet taken effect, suspending implementation timelines across healthcare, environmental, labor, and financial sectors. This memorandum operates as a blanket administrative pause, preventing dozens of rules developed through notice-and-comment procedures from becoming law, effectively allowing the administration to review and potentially rescind or modify regulations before they impose obligations on regulated entities.
The freeze directly affects multiple constituencies with competing interests. Healthcare providers and insurers face uncertainty over pending coverage and billing rules. Environmental businesses and advocacy groups lose momentum on pollution controls and emissions standards. Labor unions confront suspended workplace safety standards and wage regulations. Financial services companies benefit from delayed consumer protection rules, while consumers lose regulatory guardrails that were pending implementation. Small businesses encounter unpredictability as they attempt to plan compliance timelines.
This regulatory pause represents the opening move in a broader deregulatory agenda that accelerated through 2025 and 2026. It preceded and enabled subsequent trade actions, including the continuation of the national emergency on trade deficits in March 2026, which itself depends on reduced regulatory friction for tariff implementation. The freeze created administrative space for the administration to reshape trade policy, evident in actions like the suspension of duty-free de minimis treatment and selective tariff terminations, all of which affect consumer prices and business costs. Unlike targeted deregulation of specific rules, this memorandum wielded administrative power to halt the entire regulatory pipeline preemptively.
The legal status of this freeze has remained contested, with questions about whether a blanket suspension violates the Administrative Procedure Act's requirement that regulations become effective after proper procedural completion. Some pending rules have faced judicial review, though the breadth of the memorandum's scope has complicated litigation strategy for opponents who must challenge rules individually rather than contest the freeze itself as an overreach.
Reversing this action would require either a subsequent memorandum rescinding the freeze or a presidential administration restoring the underlying rules through new notice-and-comment procedures or congressional action mandating specific regulatory standards.
Memorandum freezing federal regulatory actions pending review
💰 Economy · Second Term (2025–present) · 🤖 AI-categorized
On January 20, 2025, the Trump administration signed Memorandum 2025-01906 directing a freeze on pending federal regulatory actions. The freeze halts the issuance and effective date of regulations that have not yet taken effect. The immediate effect is that dozens of pending rules across federal agencies are suspended pending review, affecting regulatory implementation timelines across healthcare, environmental, labor, and financial sectors.